Ranitidinebase , ≥98% , 66357-35-5

CAS NO.：66357-35-5

Empirical Formula: C13H22N4O3S

Molecular Weight: 314.4

MDL number: MFCD00081180

EINECS: 266-332-5

PRODUCT Properties

• Melting point: 69-70°C
• Boiling point: 437.1±45.0 °C(Predicted)
• Density: 1.184±0.06 g/cm3(Predicted)
• storage temp.: Desiccate at +4°C
• solubility: H₂O: 1.8 mg/mL
• pka: pKa 2.19±0.04 (Uncertain)
• form: solid
• color: tan
• Water Solubility: 24.7 mg/mL
• Stability: Hygroscopic
• CAS DataBase Reference: 66357-35-5(CAS DataBase Reference)
• NIST Chemistry Reference: Ranitidine(66357-35-5)
• EPA Substance Registry System: 1,1-Ethenediamine, N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N'-methyl-2-nitro- (66357-35-5)

Description and Uses

Ranitidine, a H2-receptor agonist, caused contact dermatitis within the pharmaceutical industry.

It simultaneously reduces pepsin activity and is used for treating stomach and duodenum ulcers as well as other conditions accompanied by elevated acidity of the gastrointestinal tract. Synonyms of this drug are zantac, azantac, raniplex, ranidil, and others.

Safety

• Symbol(GHS): GHS07
• Signal word: Warning
• Hazard statements: H315-H319
• Precautionary statements: P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362
• Safety Statements: 22-24/25
• WGK Germany: 2
• RTECS: KM6557000
• Hazardous Substances Data: 66357-35-5(Hazardous Substances Data)
• Toxicity: LD50 oral in rat: > 5gm/kg